GT BIOPHARMA INC (GTBP) Stock Income Statement
USA - NASDAQ:GTBP - US36254L3087 - Common Stock
0.6555 USD
-0.03 (-4.63%)
0.6896 USD
+0.03 (+5.2%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 13.21M | 14.36M | 13.58M | 21.26M | 57.52M | |||
| Research and Development | 6.12M | 5.80M | 6.47M | 8.81M | 9.59M | |||
| Selling, General, and Administrative Expenses | 7.08M | 8.57M | 7.11M | 12.45M | 47.92M | |||
| Operating Income | -13.21M | -14.36M | -13.58M | -21.26M | -57.52M | |||
| Interest Income/Expense | 294.00K | 402.00K | 615.00K | 254.00K | -709.00K | |||
| Other Income/Expense | 241.00K | 800.00K | 4.82M | 119.00K | 211.00K | |||
| Non Recurring Items | null | null | 547.00K | null | 0 | |||
| Income Before Taxes | -11.67M | -13.16M | -7.60M | -20.88M | -58.01M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -11.67M | -13.16M | -7.60M | -20.88M | -58.01M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.6968 | -6.937 | -5.64 | -19.66 | -61.81 | |||
| Non GAAP EPS | null | null | -5.79 | -20.1 | -80.1 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD